Kyu Chan Kwon

Title: Kyu Chan Kwon: Innovator in Erythropoietin Formulation

Introduction

Kyu Chan Kwon is a notable inventor based in Seoul, South Korea, recognized for his contributions to the field of biotechnology. His innovative work in developing a stable formulation of human erythropoietin reflects his commitment to advancing medical science and improving patient care.

Latest Patents

Kyu Chan Kwon holds a patent for his invention titled "Stable, aqueous solution of human erythropoietin, not containing serum albumin." This groundbreaking patent describes an aqueous formulation of human erythropoietin that boasts long-term storage stability without the inclusion of serum albumin. The formulation contains a pharmaceutically effective amount of human erythropoietin, along with non-ionic surfactants, polyhydric alcohols, neutral amino acids, sugar alcohols as stabilizers, isotonic reagents, and buffering reagents. This in-depth formulation aims to enhance the shelf-life and efficacy of erythropoietin treatments.

Career Highlights

Kyu Chan Kwon is part of LG Life Sciences, a prominent company involved in biotechnology and pharmaceuticals. His tenure at this company showcases his expertise and dedication to innovation within the industry.

Collaborations

Throughout his career, Kyu Chan Kwon has collaborated with esteemed colleagues, including Suk Young Choi and Young Cheol Kang. These partnerships have likely contributed to his successful patent and the development of advanced pharmaceutical formulations.

Conclusion

Kyu Chan Kwon's invention represents a significant advancement in the formulation of human erythropoietin, which has potential applications in the treatment of various conditions. With a solid foundation in biotechnology and collaborative efforts with fellow innovators, Kwon continues to be a key figure in the realm of life sciences.